家长注意了 这种呼吸道病毒专盯小宝宝

Core Insights - Respiratory Syncytial Virus (RSV) is a common respiratory virus and a leading cause of acute lower respiratory infections in children under 5 years old [1][4] - RSV spreads primarily through respiratory droplets and close contact, with increased transmission in crowded and poorly ventilated environments, especially during winter [3] - Symptoms of RSV infection resemble other respiratory illnesses and can lead to severe conditions like bronchiolitis or pneumonia in young children [4] Group 1: Understanding RSV - RSV is a major pathogen for acute lower respiratory infections in children under 5, with most children infected by age 2 [1] - Infection does not confer permanent immunity, leading to potential recurrent infections [1] Group 2: Symptoms and Risks - Symptoms include cough, nasal congestion, fever, and can develop into severe respiratory issues, particularly in infants [4] - RSV is a leading cause of hospitalization in infants, with long-term health risks such as impaired lung function and asthma [4] Group 3: Prevention Measures - Preventive measures include breastfeeding for at least 6 months, improving ventilation, avoiding crowded places, hand hygiene, and maintaining good sanitation practices [4][6] Group 4: Monoclonal Antibody Treatment - Currently, there is no vaccine for RSV in infants, but a monoclonal antibody has been approved in China to provide passive immunity [6] - The antibody works by binding to the RSV surface protein, preventing the virus from entering human cells [6] Group 5: Administration Guidelines - WHO recommends administering the RSV monoclonal antibody to infants born during the RSV season immediately after birth or at the start of the RSV season for those born before [7] Group 6: Appointment Information - In Beijing, RSV monoclonal antibody appointments can be made through specific health service applications [9][11] - A prescription from a pediatrician is required for the administration of the RSV monoclonal antibody [13]